This finding is supported by previous research indicating that in morbidity obese women with non-alcoholic fatty liver disease, the hepatic mRNA expressions of hepcidin and FPN were significantly greater than in obese women with normal liver45. Here, HAMP is linked to metabolic dysfunction-associated steatotic liver disease.